Cumberland Pharmaceuticals (CPIX) FCF Margin (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted FCF Margin of 4.24% for Q1 2026, up 19065.65% sequentially from 0.02% in Q4 2025, and down 2864.0% YoY from 0.15% in Q1 2025.
Cumberland Pharmaceuticals (CPIX) FCF Margin (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported FCF Margin for 17 years, with the latest figure at 4.24% in Q1 2026.
- Quarterly FCF Margin fell 2864.0% year-over-year to 4.24% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3.27% (down 976.0% YoY) and the FY2025 annual result came in at 10.86%, up 1265.0% from the prior year.
- FCF Margin climbed to 4.24% in Q1 2026 per CPIX's latest filing, from 0.02% in the prior quarter.
- Over five years, FCF Margin peaked at 47.42% in Q2 2023 and troughed at 25.63% in Q1 2024.
- A 5-year average of 10.14% and a median of 7.54% in 2025 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2024 and 2025: FCF Margin tumbled 5618 bps in 2024, then surged 5851 bps in 2025.
- Over 5 years, FCF Margin stood at 41.56% in 2022, then tumbled by 74 bps to 10.6% in 2023, then soared by 72 bps to 18.23% in 2024, then sank by 100 bps to 0.02% in 2025, then surged by 19066 bps to 4.24% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 4.24%, 0.02%, and 1.97% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 117.68 Mn | 113.82 Mn | - | -2,356.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,356.62% |
| Mar 31, 2026 | 4.24% |
| Dec 31, 2025 | 0.02% |
| Sep 30, 2025 | 1.97% |
| Jun 30, 2025 | 7.54% |
| Mar 31, 2025 | 32.88% |
| Dec 31, 2024 | 18.23% |
| Sep 30, 2024 | 5.06% |
| Jun 30, 2024 | -8.76% |
| Mar 31, 2024 | -25.63% |
| Dec 31, 2023 | 10.60% |
| Sep 30, 2023 | 11.73% |
| Jun 30, 2023 | 47.42% |
| Mar 31, 2023 | -16.54% |
| Dec 31, 2022 | 41.56% |
| Sep 30, 2022 | 22.29% |
| Jun 30, 2022 | 21.30% |
| Mar 31, 2022 | -1.59% |
| Dec 31, 2021 | 41.37% |
| Sep 30, 2021 | -20.48% |